Dr. Edward A Trudeau M.D.

In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

A multiple sclerosis diagnosis is quite difficult since the disease presents uncertainties. The symptoms of MS are similar to other diseases that are brought about by other conditions of the central nervous system (CNS), which include diseases that infect the CNS such as AIDS, syphilis, and Lyme...

One of the most common forms of muscular dystrophy is Facioscapulohumeral Muscular Dystrophy (FSHD). FSHD mainly affects the upper part of the body, causing muscular weakness in the facial muscles, shoulders, and arms.FSHD was classified as a separate form of muscular dystrophy in the late 20th...

In patients with muscular dystrophy, contractures usually occur as muscle breaks down. They begin at a very tender age of about 8 to 13. What this means is that muscles and tendons of the patient's wrists and hands tighten. Did you know that not all muscles lose strength at the same time? Hand...

Parkinson’s is among the most common neurodegenerative and movement disorders that touches the lives of approximately 1% of the population over the age of 60. It is more common among men than women, which suggests apart from genetics, hormonal and environmental factors may play a role. Although...

In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...